CONQUER Archives - Medical Conferences

Less medication use and fewer doctor visits with galcanezumab in treatment-resistant migraine

Presented By

Prof. Julio P. Gómez, Hospital Universitario Marqués de Valdecilla, Spain

Trial

Phase 3, CONQUER

Conference

MTIS 2020

27 October 2020 15:16

Sustained shift in migraine status using galcanezumab

Presented By

Dr William S. Kingston, Sunnybrook Health Sciences Centre, Canada

Trial

Phase 3, CONQUER

Conference

MTIS 2020

27 October 2020 14:35

Injection-site reactions with galcanezumab are mild and self-limiting

Presented By

Dr V.L. Stauffer

Trial

Phase 3, CONQUER

Conference

MTIS 2020

27 October 2020 14:27

Effects of galcanezumab on health-related quality of life

Presented By

Dr Stewart Tepper, Geisel School of Medicine, USA

Trial

Phase 3, CONQUER

Conference

EAN 2020

Type

Peer-reviewed article

9 September 2020 16:44

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com